Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MRGPRX4 | Q96LA9 | 3/20 | 0.47 |
| ▸ | CNR2 | P34972 | 6/20 | 0.43 |
| ▸ | CNR1 | P21554 | 6/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | SGMS2 | Q8NHU3 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | CYP3A5 | P20815 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | CETP | P11597 | 4/20 | 0.41 |
| ▸ | FAAH | O00519 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL485784 | 0.88 | CXCR2 (0.44) | MRGPRX4CNR2CNR1KMT2AMEN1 | |
| SCHEMBL485710 | 0.87 | MRGPRX4 (0.56) | MRGPRX4CNR2CNR1KMT2AMEN1 | |
| SCHEMBL485579 | 0.86 | CXCR2 (0.47) | CNR2CNR1KMT2AMEN1ALDH1A1 | |
| SCHEMBL486088 | 0.85 | MRGPRX4 (0.56) | MRGPRX4CNR2CNR1KMT2AMEN1 | |
| SCHEMBL485790 | 0.84 | CXCR2 (0.47) | CNR2CNR1KMT2AMEN1ALDH1A1 | |
| Formic Acid SCHEMBL27693269 | 0.83 | MRGPRX4 (0.54) | MRGPRX4CNR2CNR1KMT2AMEN1 | |
| SCHEMBL486231 | 0.83 | CXCR2 (0.52) | MRGPRX4CNR2CNR1KMT2AMEN1 | |
| SCHEMBL485783 | 0.83 | MRGPRX4 (0.47) | MRGPRX4CNR2CNR1KMT2AMEN1 | |
| SCHEMBL485826 | 0.82 | MRGPRX4 (0.51) | MRGPRX4KMT2AGAAFAAH | |
| SCHEMBL485504 | 0.82 | CXCR2 (0.51) | MRGPRX4CNR2CNR1ALDH1A1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1836158-B1 | FUSED BICYCLIC CARBOXAMIDE DERIVATIVES FOR USE AS CXCR2 INHIBITORS IN THE TREATMENT OF INFLAMMATION | SANOFI AVENTIS DEUTSCHLAND (DE) | 2012-02-01 | — | — | EP | claimed |